Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: Development of highly active anti-Pneumocystis bisbenzamidines: insight into the influence of selected substituents on the in vitro activity
D.
Maciejewska
*a,
J.
Żabiński
a,
M.
Rezler
a,
P.
Kaźmierczak
a,
M. S.
Collins
bc,
L.
Ficker
bc and
M. T.
Cushion
*bc
aDepartment of Organic Chemistry, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1 Street, 02-097 Warsaw, Poland. E-mail: dmaciejewska@wum.edu.pl
bDivision of Infectious Diseases, Department of Internal Medicine, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267, USA. E-mail: cushionmt@ucmail.uc.edu
cCincinnati Veterans Affairs Medical Center, 3200 Vine Street, Cincinnati, OH 45220, USA
First published on 7th November 2017
Abstract
Correction for ‘Development of highly active anti-Pneumocystis bisbenzamidines: insight into the influence of selected substituents on the in vitro activity’ by D. Maciejewska et al., Med. Chem. Commun., 2017, 8, 2003–2011.
The authors regret that on page 7 of their article the name for compound 13 contains an error. The correct name for 13 is: 1,5-bis(4-amidino-2-nitrophenoxy)-3-oxapentane dihydrochloride (with -2- instead of -3-nitrophenoxy).
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2017 |